Altair Nanotechnologies, Inc.
 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (date of earliest event reported):    August 9, 2007
 
 
Altair Nanotechnologies Inc. 

 (Exact Name of Registrant as Specified in its Charter)
 
 
 
Canada
 
1-12497
 
33-1084375
(State or other jurisdiction of
incorporation or organization)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
 
 
 
 
 
 
 
 
 
204 Edison Way
Reno, NV
 
 
 
 
89502
(Address of Principal Executive Offices)
 
 
 
(Zip Code)

 

 
 
Registrant's Telephone Number, Including Area Code:
 
 
(775) 856-2500
 
 
 
 
 
 
 
 
N/A
 
 
(Former name, former address, and formal fiscal year, if changed since last report)
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act  (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)
 
 


Item 2.02 Results of Operations and Financial Condition.

On August 9, 2007, Altair Nanotechnologies Inc. (the "Company") issued a press release entitled “Altair Nantechnologies Reports Second Quarter 2007 Financial Results.” The full text of the press release is provided herewith as Exhibit 99.1.

The information in Item 2.02 of this Report (including exhibit 99.1) shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d)  Exhibits.

99.1 Press Release issued by the Company dated August 9, 2007
 
2


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Altair Nanotechnologies Inc.

 
Dated: August 9, 2007
By:
/s/ Edward Dickinson                                                    
 
 
Edward Dickinson, Chief Financial Officer
 
 
3